These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 11156811

  • 1. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    Van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavallee YJ, Nandy S, Pecknold JC, Hadrava V, Swinson RP.
    Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
    [Abstract] [Full Text] [Related]

  • 2. Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
    Walker JR, Van Ameringen MA, Swinson R, Bowen RC, Chokka PR, Goldner E, Johnston DC, Lavallie YJ, Nandy S, Pecknold JC, Hadrava V, Lane RM.
    J Clin Psychopharmacol; 2000 Dec; 20(6):636-44. PubMed ID: 11106135
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
    Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM.
    Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
    [Abstract] [Full Text] [Related]

  • 4. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR, Gelenberg AJ, Munjack D.
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [Abstract] [Full Text] [Related]

  • 5. Sertraline for social phobia: a double-blind, placebo-controlled crossover study.
    Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC.
    Am J Psychiatry; 1995 Sep; 152(9):1368-71. PubMed ID: 7653696
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
    Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM.
    J Clin Psychiatry; 2003 Jul; 64(7):785-92. PubMed ID: 12934979
    [Abstract] [Full Text] [Related]

  • 7. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
    Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM.
    Arch Gen Psychiatry; 2001 May; 58(5):485-92. PubMed ID: 11343529
    [Abstract] [Full Text] [Related]

  • 8. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV, Guelfi JD, Lane RM, Cassano GB.
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [Abstract] [Full Text] [Related]

  • 9. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.
    Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
    Panahi Y, Moghaddam BR, Sahebkar A, Nazari MA, Beiraghdar F, Karami G, Saadat AR.
    Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
    Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.
    J Clin Psychiatry; 2003 Jun; 64(6):640-7. PubMed ID: 12823077
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
    Mulholland C, Lynch G, King DJ, Cooper SJ.
    J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
    [Abstract] [Full Text] [Related]

  • 20. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
    Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T.
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):9-18. PubMed ID: 14716694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.